• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . Cardiovascular post-acute sequelae of SARS-CoV-2 in children and adolescents: cohort study using electronic health records

tetano

Editor, Senior Moderator
Nat Commun


. 2025 Apr 11;16(1):3445.
doi: 10.1038/s41467-025-56284-0. Cardiovascular post-acute sequelae of SARS-CoV-2 in children and adolescents: cohort study using electronic health records

Bingyu Zhang[SUP] 1 2 [/SUP], Deepika Thacker[SUP] 3 [/SUP], Ting Zhou[SUP] 1 4 [/SUP], Dazheng Zhang[SUP] 1 4 [/SUP], Yuqing Lei[SUP] 1 4 [/SUP], Jiajie Chen[SUP] 1 4 [/SUP], Elizabeth A Chrischilles[SUP] 5 [/SUP], Dimitri A Christakis[SUP] 6 [/SUP], Soledad Fernandez[SUP] 7 [/SUP], Vidu Garg[SUP] 8 9 [/SUP], Susan Kim[SUP] 10 [/SUP], Abu S M Mosa[SUP] 11 [/SUP], Marion R Sills[SUP] 12 13 [/SUP], Bradley W Taylor[SUP] 14 [/SUP], David A Williams[SUP] 15 [/SUP], Qiong Wu[SUP] 1 4 16 [/SUP], Christopher B Forrest[SUP] #[/SUP][SUP] 17 [/SUP], Yong Chen[SUP] #[/SUP][SUP] 18 19 20 21 22 23 [/SUP]



Affiliations
Abstract

The risk of cardiovascular outcomes following SARS-CoV-2 infection has been reported in adults, but evidence in children and adolescents is limited. This paper assessed the risk of a multitude of cardiac signs, symptoms, and conditions 28-179 days after infection, with outcomes stratified by the presence of congenital heart defects (CHDs), using electronic health records (EHR) data from 19 children's hospitals and health institutions from the United States within the RECOVER consortium between March 2020 and September 2023. The cohort included 297,920 SARS-CoV-2-positive individuals and 915,402 SARS-CoV-2-negative controls. Every individual had at least a six-month follow-up after cohort entry. Here we show that children and adolescents with prior SARS-CoV-2 infection are at a statistically significant increased risk of various cardiovascular outcomes, including hypertension, ventricular arrhythmias, myocarditis, heart failure, cardiomyopathy, cardiac arrest, thromboembolism, chest pain, and palpitations, compared to uninfected controls. These findings were consistent among patients with and without CHDs. Awareness of the heightened risk of cardiovascular disorders after SARS-CoV-2 infection can lead to timely referrals, diagnostic evaluations, and management to mitigate long-term cardiovascular complications in children and adolescents.


 
Back
Top Bottom